SHARDACROP.NSE News

In this briefing: PhonePe IPO: Key Takeaways from Founder’s Media Interactions APAC Healthcare Weekly (April 19) – Fosun Pharma, Remegen, Daiichi Sankyo, Astellas Pharma, Telix Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe 1. PhonePe IPO: Key Takeaways from Founder’s Media Interactions In this insight, we discuss the important takeaways from 20+ media interactions by the founders of Phonepe Pvt Ltd (1732974D IN) This discusses about their thoughts on engineering philosophy , work culture, various regulatory challenges among others Finally, we share our overall view based on these interviews. 2. APAC Healthcare Weekly (April 19) – Fosun Pharma, Remegen, Daiichi Sankyo, Astellas Pharma, Telix Fosun Pharmaceutical received NMPA approval for Phase I/II clinical trial of CAR-T cell drug candidate FKC289. RemeGen received $650M upfront payment from AbbVie under the exclusive license agreement for RC148.

In this briefing: Primer: CRCC High Tech Equipment Corp Ltd (H) (1786 HK) - Apr 2026 Monthly Container Shipping Tracker Weekly Deals Digest (19 Apr) - Makino, Arclands, Makino, Sankei, Evergrande, Monash, Victory Giant Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums AEVEX Corp (AVEX): Defense Tech Demand Fuels Powerful First-Day Aftermarket Move 1. Primer: CRCC High Tech Equipment Corp Ltd (H) (1786 HK) - Apr 2026 Dominant Market Leader in China: CRCC High Tech Equipment (CRCCE) is the largest manufacturer of large railway track maintenance machinery in China, holding a domestic market share of over 80%. This dominant position is reinforced by its status as a subsidiary of the state-owned China Railway Construction Corporation (CRCC), providing significant competitive advantages. Favorable Industry Tailwinds: The company is poised to benefit from sustained investment in China's extensive high-speed rail network, which requires ongoing and advanced maintenance. The global railway maintenance machinery market is projected to grow steadily, with the Asia-Pacific region, particularly China, being the primary driver.

In this briefing: APAC Healthcare Weekly (April 19) – Fosun Pharma, Remegen, Daiichi Sankyo, Astellas Pharma, Telix Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) 1. APAC Healthcare Weekly (April 19) – Fosun Pharma, Remegen, Daiichi Sankyo, Astellas Pharma, Telix Fosun Pharmaceutical received NMPA approval for Phase I/II clinical trial of CAR-T cell drug candidate FKC289. RemeGen received $650M upfront payment from AbbVie under the exclusive license agreement for RC148. FDA has granted Priority Review to Daiichi Sankyo’s Biologics License Application for ifinatamab deruxtecan. Astellas Pharma initiates Phase 3 registrational study evaluating setidegrasib as first-line treatment for pancreatic ductal adenocarcinoma. Telix and Regeneron Pharmaceuticals is collaborating to jointly develop and commercialize radiopharmaceutical therapies.

In this briefing: Monthly Container Shipping Tracker Weekly Deals Digest (19 Apr) - Makino, Arclands, Makino, Sankei, Evergrande, Monash, Victory Giant Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums AEVEX Corp (AVEX): Defense Tech Demand Fuels Powerful First-Day Aftermarket Move Intertek: Bid Reflects Break-Up Value — Now a Higher Bid Trade 1. Monthly Container Shipping Tracker Spot freight rates are fading again in mid-April, despite ongoing conflict in Strait of Hormuz Spot fuel prices remain high and we believe Q126 OP margins will show sharp compression We expect shares in container segment to give back all of March's gains, and then some 2. Weekly Deals Digest (19 Apr) - Makino, Arclands, Makino, Sankei, Evergrande, Monash, Victory Giant A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Thailand, Korea, India and Chinese ADRs. ECM developments: Huaqin (3296 HK) , Victory Giant (2476 HK) and Shanghai Xizhi Technology (Lightelligence) (LIG HK) HKEx listings.

In this briefing: Weekly Deals Digest (19 Apr) - Makino, Arclands, Makino, Sankei, Evergrande, Monash, Victory Giant Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums AEVEX Corp (AVEX): Defense Tech Demand Fuels Powerful First-Day Aftermarket Move Intertek: Bid Reflects Break-Up Value — Now a Higher Bid Trade Marco Polo Marine Ltd: Company Update (10 April 2026) 1. Weekly Deals Digest (19 Apr) - Makino, Arclands, Makino, Sankei, Evergrande, Monash, Victory Giant A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Thailand, Korea, India and Chinese ADRs. ECM developments: Huaqin (3296 HK) , Victory Giant (2476 HK) and Shanghai Xizhi Technology (Lightelligence) (LIG HK) HKEx listings. Event-Driven developments: Evergrande Property Services (6666 HK) , Arclands Corporation (9842 JP) , Joyful Honda (3191 JP) , Makino Milling Machine Co (6135 JP) , Sankei Real Estate (2972 JP) , Monash IVF (MVF AU) . 2.

In this briefing: Hims & Hers May Have Just Rewritten Its Entire Business Model! Johnson Controls Isn’t Selling Assets—It’s Rebuilding For A Premium Future! ASML: A Close Look At The Memory Boom—What Rising EUV Adoption Means For Capacity And Revenues! Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums 1. Hims & Hers May Have Just Rewritten Its Entire Business Model! Hims & Hers Health did not report a surprise quarter, unveil a major product launch, or raise guidance when the stock rallied after Robert F. Kennedy Jr.’s announcement on peptides. That is what made the move notable. 2. Johnson Controls Isn’t Selling Assets—It’s Rebuilding For A Premium Future! Johnson Controls International is being discussed in the market because it is weighing a potential sale of its Access Control and Intrusion Detection businesses, a move that could fetch as much as $4.5 billion. On the surface, that looks like another industrial divestiture story.

In this briefing: Johnson Controls Isn’t Selling Assets—It’s Rebuilding For A Premium Future! ASML: A Close Look At The Memory Boom—What Rising EUV Adoption Means For Capacity And Revenues! Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 1. Johnson Controls Isn’t Selling Assets—It’s Rebuilding For A Premium Future! Johnson Controls International is being discussed in the market because it is weighing a potential sale of its Access Control and Intrusion Detection businesses, a move that could fetch as much as $4.5 billion. On the surface, that looks like another industrial divestiture story. In practice, it points to something broader: the company is steadily redesigning itself around businesses that are easier to run, more tightly integrated, and more exposed to structurally attractive demand pockets. 2. ASML: A Close Look At The Memory Boom—What Rising EUV Adoption Means For Capacity And Revenues!

In this briefing: ASML: A Close Look At The Memory Boom—What Rising EUV Adoption Means For Capacity And Revenues! Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe 1. ASML: A Close Look At The Memory Boom—What Rising EUV Adoption Means For Capacity And Revenues! ASML Holding N.V. reported net sales of EUR 8.8 billion in the first quarter of 2026, aligning with prior guidance. Net system sales amounted to EUR 6.3 billion, including over EUR 4.1 billion from extreme ultraviolet (EUV) system sales, reflecting contributions from two High Numerical Aperture (High NA) systems. The sales split between Logic and Memory segments was nearly balanced at 49% and 51%, respectively. 2. Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Alcoa Corporation reported a strong start to 2026, with performance driven by higher aluminum prices, stable operations, and disciplined execution across its portfolio, though underlying segment dynamics remain uneven.

In this briefing: Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe UMC (2303.TT; UMC.US): 2Q26 Could Reach To 5%-10% QoQ Growth; 8" Wafer Price Increase. 1. Alcoa Corporation: What Matters Now Is Aluminum Pricing Not Segment Divergence! Alcoa Corporation reported a strong start to 2026, with performance driven by higher aluminum prices, stable operations, and disciplined execution across its portfolio, though underlying segment dynamics remain uneven. Revenue declined sequentially due to seasonally lower shipments and disruptions affecting the Alumina segment, including logistical constraints tied to geopolitical tensions and weather-related issues. Despite this, profitability improved meaningfully, supported by stronger realized aluminum prices and favorable mark-to-market movements. 2.